
    
      The expected duration of treatment for patients who benefit from study intervention may vary,
      based on progression date. Median expected duration of study per patient is estimated as 9
      months in monotherapy and 12 months in combination therapy.

      The maximum treatment duration for non-progressive patients is up to 52 weeks.
    
  